CellMax-DNA Genetic Cancer Risk Test

CLIA-Certified Laboratory, Sunnyvale CA

DNA SAliva Collection Kit

Who Is This Test For?

All adults over the age of 18 could benefit from this test.

There is scientific evidence that you may carry a mutation associated with cancer risk if you have a 1st degree relative (siblings, parents and children) or even a 2nd degree relative (grandparents, aunts, uncles, nieces and nephews) who had cancer.



Why Get Tested?

  • Gene mutations are abnormalities in the DNA that can increase cancer risk by up to 40 times 1, 2, 3 .
  • Such genetic mutations are associated with increased cancer risk are passed down from parents to children.
  • Individuals who inherit certain mutated genes have an increased risk of developing cancer(s) in their lifetime. These cancers can be more aggressive and develop earlier in life.
  • BRCA1 and BRCA2 are two widely recognized genes known to increase the risk of breast and ovarian cancers, as well as prostate cancer, pancreatic cancer, and male breast cancer. However, many other genes can also influence your risk of developing cancer.
  • Understanding your risk for hereditary cancer is a significant step in taking charge of your health so you can proactively lower your risk of cancer such as developing a personalized, routine screening programs with your healthcare provider to help detect cancer at an earlier stage when chances of survival are at its highest 4.

Why CellMax?

  • Our test is comprehensive and looks for mutations in 98 genes and 25 hereditary cancers. Other tests offer fewer genes for fewer cancer types and will miss mutations that confer risk for cancer.   
  • It is a convenient saliva test that can be done in the comfort of your own home.
  • It is affordable.
  • It is accurate and reliable. All testing is performed at our lab in Sunnyvale California that has received government approval for clinical diagnostic testing (known as CLIA).

Hereditary Cancers & Gene Mutations List

Examines 98 Genes for Mutations associated with 25 Hereditary Cancers

Cancers: Bladder, Blood, Bone Sarcoma, Brain Tumors, Breast, Central Nervous System, Cervix, Colon, Endometrium, Esophagus, Gastric, Head and Neck, Kidney, Lip, Liver, Lung and Pleura, Miscellaneous Endocrine, Oral, Ovaries, Pancreatic Exocrine, Pancreatic Endocrine, Peripheral Nervous System, Pheochromocytoma, Prostate, Rectal, Sex Cord Tumors, Skin, Skin Basal Cell, Soft Tissue Sarcoma, Thyroid Tumors.

See full gene matrix here.


This test is conveniently packaged as a kit. Instructions for easy collection are included. You will provide a saliva sample at home and ship it directly to the laboratory in a pre-paid mailing envelope along with all completed forms. Take all medications as prescribed and do not eat, drink, smoke, chew gum, floss, or brush your teeth for 30 minutes prior to the saliva collection.

Note: CellMax DNA Genetic Cancer Risk Test requires physician authorization. You can make an appointment with your physician to discuss genetic testing and obtain authorization, or you can request authorization from an independent network physician at no extra charge.

CellMax-DNA Genetic Cancer Risk Test gives you a comprehensive picture of your inherited risk of cancer. The test result includes a personalized health risk management plan, enabling you to manage and take control of your health.

View Sample Report

Case Studies:  CellMax-DNA Genetic Cancer Test

32-year-old Man learns he has Increased Risk for Hereditary Cancer

Mr. Chen, a 32-year-old resident of Kaohsiung, has a family history of cancer, which concerned him for many years. Mr. Chen took the CellMax-DNA Genetic Cancer Risk Test, and learned that he carried a genetic mutation associated with an increased risk of cancer.

“My family has a history of cancer, but no one had ever been tested for genetic cancer risk — so I had been worried for many years. When I learned I could find out whether I personally had an increased risk for hereditary cancers through a saliva test, I decided to take it.

“I found out that I do carry a genetic mutation related to increased risk of colorectal cancer. Knowing this I will begin screening earlier, and do it more frequently that I would have otherwise.”

Mr. Chen

45-year-old Doctor takes CellMax-DNA Cancer Risk Test for Prevention

45-year-old Dr. Kuo, decide to be tested for genetic risk for cancer due to its extensive genes and cancer coverage.

“My father has cancer.  As a medical doctor, I know that some cancers are caused by inherited gene mutations passed down from parents to their children; these cancer usually have their onset at early age and can be more serious.

“I found out that CellMax Life offers a saliva test analyzing 24 inherited cancers for 98 genes. The test was more extensive than other genetic cancer risk tests I had found — I decided to take it without a second thought. My test was negative, and the result relieved my worry that I had for some time.

“I want my own children to now take the same test. I believe strongly in maintaining health through prevention: If any gene mutations are found are associated with hereditary cancer, I would try to strengthen the weakness with Chinese medicine.”

Dr. Kuo

Watch 2 minute video on how to take the saliva test.

According to the U.S. National Cancer Institute, more than 4 in 10 people in the United States will get cancer in their lifetime.

Learn More >>



  1.         Easton, Douglas F., Deborah Ford, and D. Timothy Bishop. “Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.” American journal of human genetics 56.1 (1995): 265.
  2.         Petrucelli, Nancie, Mary B. Daly, and Gerald L. Feldman. “BRCA1 and BRCA2 hereditary breast and ovarian cancer.” (2013).
  3.         Antoniou A, Pharoah PDP, Narod S, et al. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies. American Journal of Human Genetics. 2003
  4.        https://www.cancer.org/cancer/ovarian-cancer/detection-diagnosis-staging/survival-rates.html